Elixiron Immunotherapeutics Competitors and Similar CompaniesClear all
Elixiron Immunotherapeutics's competitors and similar companies include CEL-SCI, Valin Technologies and Topas Therapeutics.
 Elixiron Immunotherapeutics Elixiron Immunotherapeutics is a biotechnology company that develops therapies for immunological and degenerative diseases. |  CEL-SCI CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases. |  Valin Technologies Valin Technologies is a biotechnology company that researches and develops biological therapeutics. |  Topas Therapeutics Topas Therapeutics is a development stage company that intends to build neuro based pipeline of clinical-stage development therapeutics and projects to treat autoimmune diseases such as multiple sclerosis. | |
Founding Date | Founding Date 2017 | Founding Date 1983 | Founding Date N/A | Founding Date 2013 |
Type | Type Private | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations TW HQ | Locations Vienna, US HQ | Locations Yavne, IL HQ | Locations Hamburg, DE HQ Bremen, DE |
Employees | Employees 19 | Employees N/A | Employees 12 | Employees N/A |
Funding | ||||
Latest funding round | Latest funding round $ 27m (almost 5 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 5m (over 8 years ago) |
Total funding raised | Total funding raised $ 37.5m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 20.8m |
For sources of this data, please see the company profile
View Company Profiles
CEL-SCI
HQ
Vienna, US
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
View companyValin Technologies
HQ
Yavne, IL
Employees
12
Valin Technologies is a biotechnology company that researches and develops biological therapeutics.
View companyTopas Therapeutics
HQ
Hamburg, DE
Topas Therapeutics is a development stage company that intends to build neuro based pipeline of clinical-stage development therapeutics and projects to treat autoimmune diseases such as multiple sclerosis.
View company